For example, the greater the number of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment, the better the anti-tumor effect (296); and tumors manifesting PD-L1 overexpression usually portend clinical outcomes superior to those of ICI compared with those with lower levels of ligand (297) (5). The gene discussed is CD274; the disease is neoplasm.